Cardiovascular effects of intravenous midazolam after open heart surgery

Area of Science:

• Pediatric Intensive Care Medicine
• Cardiovascular Physiology
• Anesthesiology

Background:

• Midazolam is a common sedative in pediatric intensive care units (PICUs).
• It is typically administered via continuous intravenous infusion, sometimes with a bolus dose.
• Children undergoing cardiac surgery require careful hemodynamic monitoring postoperatively.

Purpose of the Study:

• To evaluate the hemodynamic effects of an intravenous midazolam bolus followed by infusion in ventilated children after cardiac surgery.
• To assess the impact on cardiac output, blood pressure, and oxygenation.
• To provide evidence-based recommendations for midazolam administration in this patient population.

Main Methods:

• Ten hemodynamically stable, ventilated children receiving morphine infusions post-cardiac surgery were studied.
• An intravenous bolus of midazolam was administered, followed by a continuous infusion.
• Hemodynamic parameters were recorded before the bolus and at 15 minutes and 1 hour post-bolus.

Main Results:

• A midazolam bolus caused a significant 24.1% decrease in cardiac output.
• Arterial blood pressure, oxygen consumption, and mixed venous oxygen content also fell significantly.
• Hemodynamic variables showed a trend toward recovery within one hour during continuous midazolam infusion.

Conclusions:

• Intravenous midazolam bolus administration leads to a transient, detrimental reduction in cardiac output in pediatric cardiac surgery patients.
• Continuous midazolam infusion appears to allow for hemodynamic recovery.
• Limiting midazolam to continuous infusion is advised for children receiving concurrent opioid therapy in the early postoperative period.